Chaudhary
Abhishek Chaudhary, Nagpur IN
Patent application number | Description | Published |
---|---|---|
20120137187 | SYSTEM AND METHOD FOR SCAN TESTING INTEGRATED CIRCUITS - A system for scan testing an IC includes one or more scan registers, one or more scan-in pads, one or more scan-out pads, and one or more comparators. Scan test data is transmitted from the scan-in pads to the scan registers. The functional response obtained from the scan test is transmitted to the comparator. The scan-out pad transmits the expected data to the comparator. The comparator compares the expected data and the functional response data and the comparison result is stored. The test result data is transmitted at positive and negative edges of the test clock signal. | 05-31-2012 |
20120246531 | SYSTEM AND METHOD FOR DEBUGGING SCAN CHAINS - Scan chains are used to detect faults in integrated circuits but with the size of today's circuits, it is difficult to detect and locate scan chain faults, especially when the scan data in and scan data out have been compressed. A method for debugging scan chains includes selecting a scan chain for debugging using a scan chain selection block and then providing scan test vectors to the selected scan chain. The scan test vectors undergo various scan test stages to generate scan response vectors. The scan response vectors are compared with ideal response vectors to identify a failing scan chain. | 09-27-2012 |
Adeel Gulazar Chaudhary, Jeddah SA
Patent application number | Description | Published |
---|---|---|
20140072966 | GENETIC BIOMARKERS FOR GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY - The genetic biomarkers for glucose-6-phosphate dehydrogenase (G6PD) deficiency are five haplotypes representing mutations of the G6PD gene on the X chromosome. Each of these haplotypes codes for more than one non-conservative amino acid change. The present inventors have discovered that when mutations of the G6PD gene result in at least two non-conservative amino acid changes in combination, expression of the G6PD enzyme or the stability of the G6PD enzyme is severely decreased, presenting a substantial risk of disease resulting from the deficiency, even in female patients who would normally be considered asymptomatic carriers of the genetic mutation(s). | 03-13-2014 |
Aditya Chaudhary, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20150356228 | PHOTOMASK ERROR CORRECTION - Design errors generated employing a mask rule check (MRC) program are indexed and examined one by one by an automated computer program connected to a false error pattern database that contains previously known waivered patterns, a real error pattern database that contains previously known pairs of an error-containing pattern and a corresponding error-free pattern, and optionally a mask house rule database. A waiver is applied to each design error for which a matching pattern is found in the false error pattern database. Each design error for which a match is found in the real error pattern database is modified to substitute an error-free pattern for an error-containing pattern therein. The output of the automated program includes a list of design errors for which no solution is found by the automated program. | 12-10-2015 |
Alka Chaudhary, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20090263333 | Pharmaceutical compounds and compositions - The invention provides three polymorphic forms of crystalline levosalbutamol sulphate designated herein as Forms I, II and III. Crystalline levosalbutamol sulphate Form I is characterised by a powder XRD pattern with peaks at 10.8, 11.9, 13.0, 18.3, 28.5±0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form II is characterised by a powder XRD pattern with peaks at 8.7, 9.6, 15.2, 15.7, 19.1, 27.2, 30.7±0.2 degrees 2 theta. Crystalline levosalbutamol sulphate Form III is characterised by a powder XRD pattern with peaks at 5.5, 6.9, 7.3, 18.7±0.2 degrees 2 theta. Processes for making the new polymorphic forms and pharmaceutical compositions comprising them are also provided. A pharmaceutical composition comprises a therapeutically effective isomer of salbutamol or a salt, solvate, ester, derivative or polymorph thereof, a glucocorticoid and a pharmaceutically acceptable carrier or excipient and optionally one or more other therapeutic agents. Preferably the composition is an aerosol formulation comprising the drugs, a propellant and optionally one or more other ingredients, such as a surfactant, cosolvent, or bulking agent. Alternatively, DPI or inhalation suspensions may be used. | 10-22-2009 |
Alka Chaudhary, Panvel IN
Patent application number | Description | Published |
---|---|---|
20090325915 | Crystalline Levosalbutamol Sulphate and Polymorphic Forms Thereof - The invention provides three polymorphic forms of crystalline levosalbutamol sulphate designated herein as Forms I, II and III. | 12-31-2009 |
Aman Chaudhary, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140304352 | SYSTEMS AND METHODS FOR CLUSTER PARAMETER LIMIT - The present disclosure is directed towards a system and method for handling limit parameters for spillover conditions of virtual servers across multiple nodes in a cluster system. The cluster system may comprise a plurality of nodes, wherein one node may be elected as a master node and the remaining nodes are designated as slave nodes. The master node may monitor the cluster system and establish limit parameters for the cluster system and apply them to the plurality of nodes. The limit parameters may be based upon the number of open connections in the cluster system and the number of nodes. The master node may establish an ideal quota value for each node to balance the number of open connections in the cluster. | 10-09-2014 |
20140304399 | SYSTEMS AND METHODS FOR PROVIDING MONITORING IN A CLUSTER SYSTEM - The present application is directed towards systems and methods for providing monitoring in a cluster system. The systems and methods distribute the monitors for a service and the ownership of a service across a cluster system comprising a plurality of nodes. The nodes in the cluster can be configured to have different sets of virtual servers (sometimes referred to as “vservers”) and services. The ownership and monitoring of the services can be distributed among all the nodes in the cluster. The system can identify a service in a cluster system and identify a master node that has ownership of the service. The master node can transmit a service status update to other nodes in the cluster system. | 10-09-2014 |
20150039763 | SYSTEMS AND METHODS FOR LEAST CONNECTION LOAD BALANCING BY MULTI-CORE DEVICE - The present invention is directed towards systems and methods for load balancing by a multi-core device intermediary between clients and services. The device may establish sub-slots in each slot of the device's packet engines. The number of sub-slots may correspond to the packet engine count. Each slot may track a different number of active connections allocated to a service. The device may assign a first and second service to each packet engine in a first slot corresponding to no active connections. These services may be assigned to different sub-slots in adjacent packet engines. The device may update, responsive to allocation of a first active connection to the first service, the first service from a sub-slot in the first slot of a first packet engine, to a corresponding sub-slot in a second slot. The second slot may correspond to one active connection allocated to the first service. | 02-05-2015 |
Amit Chaudhary, Kathmandu NP
Patent application number | Description | Published |
---|---|---|
20130246896 | Page Creation System - Various technologies and techniques are disclosed for creating web pages for third party web sites such as Facebook. A page creation system is disclosed for creating web pages that encourage visitors to like a particular page on a third party site. Integration details are received about a third party site. Upon selecting a particular page template, the template is displayed with incomplete sections of the page template for the user to fill in. Content is received from the user for incomplete sections to form a completed page content. A create page selection is received from the user. A blurred version of a web page is created from the completed page content. A normal version of the web page that is designed for display after the blurred version is also created. The blurred version and normal version of the web page are published to the third party site. | 09-19-2013 |
Amrita Chaudhary, Varanasi IN
Patent application number | Description | Published |
---|---|---|
20140202943 | SUSTAINED SILVER RELEASE COMPOSITION FOR WATER PURIFICATION - Described herein are methods and compositions for preparing an adsorbent composition for sustained silver ion release is provided. The method comprises impregnating silver nanoparticles on an organic-templated-nanometal oxyhydroxide. Particle size of the silver nanoparticles is less than about 50 nm. The adsorbent composition is antimicrobial in water. In an aspect, the organic- templated-nanometal oxyhydroxide is organic-templated-boehmite nanoarchitecture (OTBN). The resultant adsorbent composition is used as a water filter in a water purification device. | 07-24-2014 |
20140216993 | SINGLE CONTAINER GRAVITY-FED STORAGE WATER PURIFIER - A gravity-fed storage water purifier is provided. The gravity-fed water purifier includes a filtration unit for receiving water. The filtration unit includes a housing unit, a first membrane cloth layer, a second membrane cloth layer, and a granular biocidal composition layer disposed between the first and second membrane cloth layers. The first and second membrane cloth layers remove dirt, sand and sediments from the contaminated water, using a depth filtration mechanism. The granular biocidal composition layer removes bacteria and virus from the contaminated water, through fast leaching of silver ions into the water. A single storage container is provided that collects the water filtered by the virtue of filtration unit and gravity. An adsorbent composition is disposed between the storage container and an outlet tap of the storage container. | 08-07-2014 |
20140314951 | MULTILAYER ORGANIC-TEMPLATED-BOEHMITE-NANOARCHITECTURE FOR WATER PURIFICATION - An adsorbent composition comprising a nanoscale shell of metal oxide or hydroxide on an organic-templated-boehmite-nanoarchitecture (OTBN) is provided. The nanoscale shell is prepared by impregnating OTBN with a metal or a non-metal ion, followed by in-situ hydrolysis of the deposited ion on the OTBN surface. The thickness of the shell is less than about 3 nm, which is less than the size of OTBN core. The number of layers of the shell is flexible, thereby leading to a multi-layer nanoscale hybrid composition. The adsorbent composition is capable of removing inorganic anions such as fluoride from water, with an increased adsorption capacity. | 10-23-2014 |
Amrita Chaudhary, Varanasl IN
Patent application number | Description | Published |
---|---|---|
20130292323 | AXIAL FLOW FILTER BLOCK FOR WATER PURIFICATION - A gravity-fed, axial flow filtration system for treating water is disclosed. | 11-07-2013 |
Anisha Chaudhary, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20160059517 | HIGH PERFORMANCE LIGHT WEIGHT CARBON FIBER FABRIC-ELECTROSPUN CARBON NANOFIBERS HYBRID POLYMER COMPOSITES - The present disclosure relates to the development of high performance light weight carbon fiber fabric-electrospun carbon nanofibers hybrid polymer composites and a process thereof. In this process continuous carbon nanofiber sheets of diameter in the range of few hundred nanometers are developed from electrospun PAN nanofibers and sandwich between the carbon fiber fabric epoxy resin prepregs to develop hybrid polymer composites by compression molding technique with low content of carbon fibers. | 03-03-2016 |
Anita Chaudhary, Gandhinagar IN
Patent application number | Description | Published |
---|---|---|
20120046317 | NOVEL HETEROCYCLIC COMPOUNDS - The present invention relates to a new class of heterocyclic compounds and pharmaceutically acceptable salts thereof, process for preparing the same, pharmaceutical composition containing these compounds and to their use in treatment of diseases caused due to formation and accumulation of AGEs (Advanced Glycation end products). The compounds of the present invention are useful for the treatment of diabetic and aging-related complications caused by formation and accumulation of AGEs, such as neuropathy, nephropathy, microangiopathy, retinopathy, hypertension, heart failure, atherosclerosis, Alzheimer's disease & dermatological disorders. | 02-23-2012 |
Anita Chaudhary, Gujarat IN
Patent application number | Description | Published |
---|---|---|
20090088432 | Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors - The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specification. The invention also encompasses process for preparing such compound, pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases. | 04-02-2009 |
Ashish Chaudhary, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20080236837 | COMMUNICATING MEASUREMENT DATA FROM A WELL - To communicate measurement data from a well, data corresponding to measurement data collected by multiple sensors in a well is transformed downhole and passed to an intermediate communications device, which device in turn passes a subset of that data to a destination communications device. The destination communications device applies a second transformation to the data received from the intermediate communications device. The first and second transformations are designed such that meaningful data can be recovered at the destination communications device even though only a subset of the original transformed data has been received. | 10-02-2008 |
20120181050 | METHOD AND APPARATUS FOR SETTING A PACKER - A hydraulically set packer assembly actuated over an electronic line. The assembly includes a hydraulic packer setting mechanism that serves as an intensifier that is activated by way of an electronic trigger. As such, the trigger may be electronically coupled to an electronic line that is conventionally available for surface communications between surface equipment and a downhole gauge. The gauge generally present for monitoring well conditions such as pressure. Thus, a separate dedicated hydraulic or other powering line need not be outfitted as part of the assembly. Once more, for sake of gauge and well monitoring integrity, communications with the setting mechanism may be severed upon setting of the packer. | 07-19-2012 |
Ayesha Chaudhary, Karnal IN
Patent application number | Description | Published |
---|---|---|
20110262363 | GLUCOSE BIOSENSOR SYSTEM COUPLED WITH AN ANTI-INFLAMMATORY MODULE AND METHODS FOR USING THE SAME - Disclosed are apparatuses for detecting glucose levels in a subject. The apparatuses include a glucose sensor coupled with an anti-inflammatory module. The apparatus is configured to monitor blood glucose by detecting the fluorescence generated by the sensor and simultaneously reduce the tissue inflammation reaction. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems. | 10-27-2011 |
Devendra Chaudhary, Oberschan CH
Patent application number | Description | Published |
---|---|---|
20130052369 | PLASMA REACTOR - A plasma reactor with a recipient ( | 02-28-2013 |
Devendra Chaudhary, Jaipur IN
Patent application number | Description | Published |
---|---|---|
20130333616 | PLASMA PROCESSING SYSTEM WITH MOVABLE CHAMBER HOUSING PARTS - A substrate processing system includes a vertically movable chamber section so that chamber sections are vertically separable to provide open and closed positions of a processing chamber or reactor, such as a plasma enhanced CVD chamber. In the open position, substrates are loaded and unloaded from the processing chamber, while in the closed position an enclosed processing volume is provided for processing substrates, particularly for processing large substrates (e.g., one square meter or larger) with a small gap (3-10 mm) between electrodes. Plural processing chambers can be provided and coupled to an actuator assembly for simultaneously vertically moving a chamber section or chamber portion of each processing chamber. Lift pins for receiving and positioning of substrates within the processing chambers can also be moved by the actuator assembly. A removable mounting arrangement is also provided for the lift pins. | 12-19-2013 |
Devendra Chaudhary, Jagatpura IN
Patent application number | Description | Published |
---|---|---|
20140360429 | GAS BARRIER ELEMENT FOR PECVD REACTORS - This disclosure relates to plasma processing for photovoltaic device manufacturing. Particularly to a plasma processing system that includes an electrode that allows gas to pass through into the process chamber that includes a substrate. A gas barrier component may be used to minimize parasitic plasma occurring at the edges of the electrode by preventing process gas reaching the edge of the chamber or from entering the process chamber by going around the electrode. The gas barrier component may be made of a non-conductive flexible material that forms a fluidic seal between the electrode and the chamber. In other embodiments, the gas barrier may also support isolation grids that are disposed opposite of the electrode and prevent the isolation grids from moving. | 12-11-2014 |
Devendra Kumar Chaudhary, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20130259477 | METHOD AND SYSTEM FOR REDUCING THE RESOURCE UTILIZATION OF SWITCH FABRIC IN A SONET/SDH MULTIPLEXER BY SWITCHING DATA ON A TU LEVEL - The present invention relates to a method and apparatus for reducing the resource utilization of the switching fabric in a SONET/SDH multiplexer by switching data on a TU level instead of byte or column level. | 10-03-2013 |
Doongar Ram Chaudhary, Bhavnagar IN
Patent application number | Description | Published |
---|---|---|
20140038249 | Integrated Process For The Production Of Jatropha Methyl Ester And By Products - The present invention provides a simpler and more energy efficient process for the preparation of fatty acid methyl ester (biodiesel) from sun dried whole seed capsules of | 02-06-2014 |
Jai Prakash Chaudhary, Bhavnagar IN
Patent application number | Description | Published |
---|---|---|
20150274942 | BIODEGRADABLE HYDROPHOBIC COMPOSITE MATERIALS AND PROCESS FOR THE PREPARATION THEREOF - The present invention relates to biodegradable hydrophobic composite materials and a process for the preparation of said hydrophobic biodegradable materials from the seaweed polysaccharides through grafting reaction with vinylated monomers e.g. vinyl acetate. The said composites can be used as a substitute for synthetic ropes for varied applications including seaweed cultivation in the open sea. The results of cultivation experiments showed that ropes are suitable for cultivation of seaweeds in the sea environment, and exhibit higher biomass yield as compared to synthetic ropes. The prepared composites are very flexible and can be used for making handles for carry bags and for the preparation of biodegradable designs, bowls, pots, jars, gift items, stud caps and bracelets. | 10-01-2015 |
Latha Chaudhary, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20110206788 | NOVEL HERBAL COMPOSITION - Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of | 08-25-2011 |
20140294998 | NOVEL HERBAL COMPOSITION - Disclosed herein is synergistic herbal composition comprising extracts of herbal ingredients of | 10-02-2014 |
Manu Chaudhary, Haryana IN
Patent application number | Description | Published |
---|---|---|
20080227732 | Treatment and Control of Severe Infections Including Cystic Fibrosis - The present invention provides a pharmaceutical composition comprising antibiotic combination products for delivering two or more different antibiotics simultaneously, wherein the two different antibiotics comprise one which consisting of concentration dependent killing and the other concentration independent killing or time dependant killing activity. The invention has been worked out utilizing pharmacokinetic and pharmacodynamic principles to optimize antibiotic regimen, to improve clinical results and to potentially decrease the development of resistance. Combination of ceftazidime and tobramycin has been evolved to specifically illustrate the invention. | 09-18-2008 |
20090156670 | NONAQUEOUS LIQUID PARENTERAL ACECLOFENAC FORMULATION - A nonaqueous liquid parenterally deliverable pharmaceutical formulation, and more particularly a nonaqueous liquid parenteral Aceclofenac formulation comprising the selective NSAID Aceclofenac, is disclosed. A process of preparing Aceclofenac formulation, the therapeutic dosage form and storage of dose, and the method of treating a subject having a condition or a disorder wherein treatment with NSAID is indicated, are also disclosed. Diclofenac formed by conversion of Aceclofenac is solubilized by the nonaqueous solubilizer(s), which are substantially inert with respect to such conversion. The composition has Aceclofenac salt stabilizing means for inhibiting precipitation of Aceclofenac. The compositions disclosed in the present invention are stable upon storage at room temperature and at refrigerated temperatures. Compositions disclosed in the present invention, whether ready-to-use or requiring dilution prior to administration, can be prepared by inexpensive processes disclosed herein. | 06-18-2009 |
20100160277 | COMPOSITIONS FOR COMBATING BETA-LACTAMASE-MEDICATED ANTIBIOTIC RESISTANCE USING BETA-LACTAMASE INHIBITORS USEFUL FOR INJECTION - The invention describes a composition for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitor useful for injection, capable of pharmaceutical application. The invention relates to pharmaceutical composition containing ceftriaxone (normally as ceftriaxone sodium) and sulbactam (normally as sulbactam sodium). Such compositions are found to be useful for intramuscular or intravenous administration as antibiotics for hospitalized patients with serious infections. Specifically, this invention relates to a pharmaceutical composition further including an aminocarboxylic acid chelating agent, for example, ethylenediaminetetraacetic acid (EDTA), or a pharmaceutically acceptable salt thereof. The pharmaceutical compositions of this invention have been found normally to enhance resistance to particulate formation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention also gives a process to manufacture these compositions. The invention gives a method of treating a subject having a condition or disorder, wherein a treatment with ceftriaxone sodium and sulbactam sodium is indicated. | 06-24-2010 |
20110186457 | NOVEL SINGLE UNIT CARBAPENEM AMINOGLYCOSIDE FORMULATIONS - A pharmaceutical low dose, antibiotic combination of two antibiotics selected from a carbapenem and an aminoglycoside, present as a single unit fixed low dose injection effective at very low concentrations. The antibiotic combination is suitable for the treatment of bacterial/multibacterial infections, and is particularly suitable for neonates, children, and other patients with low tolerance, and who are prone to serious fatal mixed multi-bacterial infectious diseases where potential toxicity due to higher doses is a cause for concern. | 08-04-2011 |
20130023512 | Compositions for Combating Beta-Lactamase-Medicated Antibiotic Resistance Using Beta-Lactamase Inhibitors Useful For Injection - The invention describes a composition for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitor useful for injection, capable of pharmaceutical application. The invention relates to pharmaceutical composition containing ceftriaxone (normally as ceftriaxone sodium) and sulbactam (normally as sulbactam sodium). Such compositions are found to be useful for intramuscular or intravenous administration as antibiotics for hospitalized patients with serious infections. Specifically, this invention relates to a pharmaceutical composition further including an aminocarboxylic acid chelating agent, for example, ethylenediaminetetraacetic acid (EDTA), or a pharmaceutically acceptable salt thereof. The pharmaceutical compositions of this invention have been found normally to enhance resistance to particulate formation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention also gives a process to manufacture these compositions. The invention gives a method of treating a subject having a condition or disorder, wherein a treatment with ceftriaxone sodium and sulbactam sodium is indicated. | 01-24-2013 |
20130136798 | NOVEL PARENTERAL CONTROLLED RELEASE FORMULATIONS OF NSAID'S - A controlled release parenteral formulation for treatment of pain and inflammation is provided. The formulation includes an effective amount of: one or more active drug moiety. The drug moiety is selected from a group comprising aceclofenac or diclofenac or a combination thereof; One or more solvent moiety selected from a group comprising one or more of ethyl acetate, triacetin, di methyl iso sorbide, DMA, DMSO, PEG, PVP, PVA, Span 80, DCM, Benzyl alcohol, acetone or a combination thereof. The formulation, upon administration, has a release profile including an immediate burst release and the burst release is followed by a slow release of at least 18 to 24 hrs. The immediate burst release and the slow release of the drug moiety remains within the therapeutic window of the drug moiety. | 05-30-2013 |
Manu Chaudhary, Panchkula IN
Patent application number | Description | Published |
---|---|---|
20090318378 | Antibiotic Combinations For Providing Total Solution to the Treatment of Infections - The invention relates to a new pharmaceutical composition, a method of treatment of infection and also a process to prepare the composition. The infectious complications are important causes of morbidity and mortality. Hospital acquired pneumonia (HAP) remains the most severe nosocomial infection in intensive care units. Beta-lactams alone are always considered inadequate when | 12-24-2009 |
20110257079 | Parenteral Combination Therapy for Infective Conditions With Drug Resistant Bacterium - The invention describes a pharmaceutical composition to combat multiple-drug-resistant bacteria in non-ocular infective conditions. Compositions comprising glycopeptides, in particular vancomycin, and cephalosporins, in particular ceftriaxone, are disclosed. Such compositions are found to be useful for parenteral administration for hospitalized patients with serious infections. Specifically, this invention also discloses a pharmaceutical composition further including an excipient such as CVMC agent and is available in dry powder form for reconstitution before injection with a suitable solvent. The pharmaceutical compositions of this invention have been found normally to enhance resistance to precipitation in solutions to be administered parenterally. The invention also gives details of the dosage forms stored in sealed containers to be reconstituted before use. The invention further provides a process to manufacture these compositions and also a method of treating a subject having non-ocular infective conditions due to multi drug resistant bacterium. | 10-20-2011 |
20110262499 | TOPICAL HERBAL FORMULATION FOR TREATMENT OF ACNE AND SKIN DISORDERS - The present invention provides novel herbal nano emulsion based formulations comprising a combination of lemon juice and/or rose water as therapeutically active aqueous phase entrapped in oil phase selected from one or more essential oils and process for the preparation of the same in pharmaceutically acceptable dosage forms for topical treatment of acne and other skin disorder like eczema, psoriasis, aging scaring and the like with increased efficacy, Improved percutaneous penetration, excellent thermodynamic stability ensuring long shelf life, low skin irritation and reservoir effect that promotes drug localization in the skin enabling controlled delivery of the said therapeutic agents. | 10-27-2011 |
20120093888 | MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS - A formulation to treat rheumatic disorders and related infections is provided. The formulation is a micro-emulsion including at one or more of an active ingredients. The active ingredient includes one or more of an essential oil mixed with an aqueous phase along with one or more of a surfactant and one or more of a co-surfactant. The co-surfactant is medicated by an extract of one or more of an herb. | 04-19-2012 |
20130295052 | NOVEL CONJUGATES FOR TARGETED DRUG DELIVERY - The present invention relates to a novel drug delivery system comprising a drug(s)-protein-polymer triple conjugate. The triple conjugate employs a (i) protein moiety capable of binding selectively to a particular target site possessed by a cell/affected organ, (ii) a polymer moiety, covalently linked to the protein and (iii) an active drug moiety that includes one or more drug(s) covalently linked to either said polymer moiety or to a protein moiety. The conjugates of the present invention have target specificity and better selectivity to a defined population of cells/organs(s). The present invention further relates to methods of preparation and methods of treatment comprising administering said conjugate as a single unit. The conjugates of the present invention are usefully employed in therapeutic as well as non-therapeutic, e.g., diagnostic applications. | 11-07-2013 |
20140147394 | DETOXIFIER HERBAL FORMULATION - The present invention provides a non-parenteral and non-ocular herbal synergistic detoxifier composition effective for blood purification, blood detoxification and in the treatment and management of disorders related to accumulation of toxins in the body having synergistic effect of its components in specific ratio, better bio availability wherein the amount of dose administered is remarkably low. The formulation of synergistic herbal composition has better patient compliance in the terms of palatability, ease of administration and is formulated in the form of syrup, lozenges/candies/jujubs/mouth freshener, sub-lingual tablets or chewable tablets. The present invention also provides a method of preparation of this formulation. | 05-29-2014 |
Nitin Chaudhary, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20120116677 | ASSISTED POSITIONING SYSTEMS - A position determining unit has an assistance data processing and relaying module (software client) ( | 05-10-2012 |
Nveed Chaudhary, Southampton GB
Patent application number | Description | Published |
---|---|---|
20100204211 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 08-12-2010 |
20110076238 | COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES - The invention relates to the use of anticholinergics for preparing a pharmaceutical composition for the prevention and treatment of proliferative processes. | 03-31-2011 |
20120004202 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 01-05-2012 |
20140296217 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 10-02-2014 |
Nveed Chaudhary, Middlesex GB
Patent application number | Description | Published |
---|---|---|
20090048267 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 02-19-2009 |
Nveed Chaudhary, Neuchatel CH
Patent application number | Description | Published |
---|---|---|
20140128409 | MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES - The present invention relates to the use of indolinones of general formula | 05-08-2014 |
Parveen Kumar Chaudhary, Delhi IN
Patent application number | Description | Published |
---|---|---|
20110202393 | INTEGRATED SYSTEM AND METHOD FOR CAR POOLING USING SMART CARDS, GPS, GPRS, ACTIVE POSTER AND NEAR FIELD COMMUNICATION DEVICES - A method, integrated system and in-vehicle Active Poster for processing mobile touch transactions including carpooling transactions. The integration includes a near field contactless or swipe smart card or other portable identification device which may be standalone, affixed to, or part of a mobile or hand held portable wireless communication device, a touch sensitive Active Poster also with swipe or near field contactless communication capability and also incorporating or in communication with GPS or other vehicle location services capability for the vehicle, a car pool management or other service provider's system and application and a host computer with networking capability. | 08-18-2011 |
20110202417 | INTEGRATED SYSTEM AND METHOD FOR ENABLING MOBILE COMMERCE TRANSACTIONS USING ACTIVE POSTERS AND CONTACTLESS IDENTITY MODULES - A method, integrated system and Active Poster for processing mobile touch transactions. The integration consists of an RFID or other near field communication enabled device which may be standalone, affixed to, or part of a mobile or hand held portable wireless communication device (optionally using a Contact Less (CL) SIM with near field communication capability), a touch sensitive Active Poster also with near field communication capability, an issuer's or mobile network provider's system and application and a host computer with networking capability. | 08-18-2011 |
Preeti Madhukar Chaudhary, Pune IN
Patent application number | Description | Published |
---|---|---|
20120225877 | SUBSTITUTED 1, 4-DIOXA-8-AZASPIRO[4,5]DECANES USEFUL AS FUNGICIDES AND A PROCESS FOR THE PREPARATION THEREOF - This invention relates provides novel substituted 1,4-dioxa-8-azaspiro[4,5]decane of general formula (1), wherein R1 is selected from phenethyl, 4,6-dimethoxypyrimidin-2-yl and (2-chloro-5-thiazolyl)methyl and R2 is selected from the group consisting of hydroxy, 4-bromo-2-chlorophenoxy, morpholin-4-yl, (2-chloro-5-thiazolyl)methyloxy, benzyloxy, phenylsulfanyl, benzotriazol-1-yl and 5-chloro-2-fluoroanilino. The present invention also relates to a process for the preparation of novel substituted 1,4-dioxa-8-azaspiro[4,5]decanes of general formula (1). The novel substituted 1,4-dioxa-8-azaspiro[4,5]decane of general formula (1) has fungicidal activity. | 09-06-2012 |
20130060045 | 1, 2, 4-TRIAZOLE DERIVATIVES AND THEIR ANTI MYCOBACTERIAL ACTIVITY - Invention provides antitubercular compounds selected from propargylated 1,2,3 triazoles of Formula I, wherein, X is sulfur (S) or a sulphone (A), n, m represent independently an integer O or 1, with the provision that when ‘n’ is 1, ‘m’ is 1; R1 is hydrogen; C1-C6 linear or branched alkyl group optionally substituted with aryl group; halogen; or aryl group optionally substituted with —OCH3, halogen, and nitro; R2 and R3 are selected from the group consisting of hydrogen, C1-C6 alkyl optionally substituted with heterocyclic ring of 5 to 6 ring atoms containing one to three hetero atoms selected from oxygen, sulfur, nitrogen, which may be substituted with alkyl, arylalkyl, linear or branched alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or allyl or propargyl groups consisting of 1 to 6 carbon atoms; Z is C1-C6 alkyl optionally substituted with heterocyclic ring of 1 to 6 ring atoms, containing one to three hetero atoms selected from oxygen, sulfur, nitrogen, which may be substituted with arylalkyl, linear or branched alkenyl, substituted alkenyl, alkynyl, substituted alkynyl allyl or propargyl groups consisting of 1 to 6 carbon atoms; with the provision that when ‘m’ is 1, and ‘n’ is zero; R1 is selected from the group consisting of hydrogen, halogen; C1-C6 linear or branched alkyl group optionally substituted with aryl group or aryl group optionally substituted with —OCH3, halogen, and nitro, R2 and R3 are selected from the group consisting of hydrogen, C1-C6 alkyl optionally substituted with heterocyclic ring of 5 to 6 ring atoms containing one to three hetero atoms selected from oxygen, sulfur, nitrogen, which may be substituted with alkyl, arylalkyl, linear or branched alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, or allyl or propargyl groups consisting of 1 to 6 carbon atoms; Z is selected from the group consisting of halogen, C1-C6 linear or branched alkyl group optionally substituted with heterocyclic ring of 1 to 6 ring atoms, containing one to three hetero atoms selected from oxygen, sulfur, nitrogen, wherein the heterocyclic ring may further be substituted with halogen, alkyl, arylalkyl. | 03-07-2013 |
20150073026 | 1, 2, 4-TRIAZOLE DERIVATIVES AND THEIR ANTI-MICROBIAL ACTIVITY - Triazole derivatives useful as anti-tubercular compounds; process for preparation of the triazoles and a method for inhibiting growth of | 03-12-2015 |
Sanjay Kumar Chaudhary, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20090147414 | GROUND FAULT DETECTION IN AN UNGROUNDED ELECTRICAL SYSTEM - An ungrounded electrical power distribution system may experience a single line to ground fault. Such a fault may not disrupt operation of the system, but its presence may raise a risk of additional problems if left uncorrected. A system for progressively grounding the ungrounded system may be initiated when a line to ground fault is suspected. As grounding through successively lower impedance proceeds, fault current may increase and detection of severity of the line to ground fault may be more readily achieved, thus facilitating localization of the fault. | 06-11-2009 |
20090147415 | GROUND FAULT DETECTION AND LOCALIZATION IN AN UNGROUNDED OR FLOATING DC ELECTRICAL SYSTEM - An ungrounded or floating DC electrical power distribution system may experience a single line to ground fault. Such a fault may not disrupt operation of the system, but its presence may raise a risk of additional problems if left uncorrected. A system for progressively grounding the ungrounded system may be initiated when a line to ground fault is suspected based on the voltage difference measured to a common chassis point. As grounding through successively lower impedance proceeds, fault current may increase and detection of severity of the line to ground fault may be more readily achieved, thus facilitating localization of the fault. Localization may be achieved through an analysis of direction of capacitive currents in isolatable zones of the system. | 06-11-2009 |
Sanjay Kumar Chaudhary, Aalborg DK
Patent application number | Description | Published |
---|---|---|
20100219838 | METHOD OF DETECTING THE WET ARC FAULT IN THE AC POWER DISTRIBUTION APPLICATIONS - Methods for detecting wet arc faults are based on the direct current (DC) signature analysis and pattern matching pertaining to wet arc characteristics. While magnifying some wet arc fault signatures, it may be found that the wet arc current signal itself resembles a normal current signal in both time and frequency domains. The change in magnitude or high frequency behavior found may not be enough to distinguish a wet arc fault signature from a normal signature. Embodiments of the present invention may look at the magnitude change in the DC content per cycle of the wet arc current signal, which may be more positive in one cycle while, in the next cycle, it may be negative in a relative manner. A particular number of these changes may be determinative of a wet arc fault. | 09-02-2010 |
20100259859 | METHOD OF ENSURING THE COORDINATED ARC FAULT PROTECTION IN A HEIRARCHIAL POWER DISTRIBUTION SYSTEM - A coordinated arc fault protection scheme in a hierarchical power distribution system is disclosed. The methods according to embodiments of the present invention may be considered an “event and time graded” analysis. In event and time based analysis, the number of confirmed arc signature may be monitored with respect to time in the main feeder line as well as the branched feeders. The confirmed arc signature in the branched feeder, as well as in the main feeder, may be captured and time stamped. A trip command may be issued first in the intended branched feeder if the branched feeder experiences a minimum number of events within a given time. During the same time period, the main feeder also monitors similar arcing events. If the tripping of the branched feeder occurs and the main feeder still detects arcing events, the main feeder may be tripped after a certain period of time or a certain number of confirmed arc signature. If there is no arc in the branched feeder and the main feeder itself experiences the arc, then the main feeder may be tripped after a predetermined period of time so that the current to all the branched feeders may be cut and the main feeder may be protected. | 10-14-2010 |
Sartaj Chaudhary, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120027064 | Identifying Rogue GSM Base Stations by Intercepting Downlink Beacon Channels - System and methods and memory media for identifying a rogue base station. A receiver captures an input signal that includes a mixture of the rogue station's transmission and the transmission of a victim base station. The victim station's transmission is removed from the mixture. A plurality of channel signals are extracted from the residual signal. The channel signals are analyzed which of them are “valid”, i.e., contain a GMSK-modulated GSM signal. The “valid” channel signals are low pass filtered and then analyzed to determine which of them corresponds to the beacon channel. Information identifying the rogue base station is extracted from the beacon channel. | 02-02-2012 |
20130216005 | Blind Mechanism for Demodulating Offset QPSK Signals in the Presence of Carrier Phase Error - A computer-implemented system and method for blind demodulation of an offset QPSK input signal, involving repeatedly performing a set of operations, including: (a) applying a phase correction to the input signal based on an estimate of a carrier phase offset of the input signal to obtain a first modified signal; (b) shifting a quadrature component of the first modified signal by half a symbol period relative to an inphase component to obtain a second modified signal; (c) extracting a first sequence of symbols from the second modified signal, where the extraction includes estimating a symbol timing offset from the second modified signal; (d) performing hard-decision demodulation on the first sequence of symbols to obtain a second sequence of reference symbols; (e) computing a phase difference between the first sequence of symbols and second sequence of reference symbols; and (f) updating the carrier phase offset estimate using the phase difference. | 08-22-2013 |
Seema Chaudhary, Gurgaon IN
Patent application number | Description | Published |
---|---|---|
20140309182 | INSECTICIDAL COMPOUNDS FROM NOTHAPODITES FOETIDA AND PROCESS FOR THE EXTRACTION THEREOF - The present invention relates to an insecticidal enriched extract (biopesticide) isolated from the stem of | 10-16-2014 |
Shilpa Chaudhary, Noida IN
Patent application number | Description | Published |
---|---|---|
20150185505 | METHOD AND SYSTEM FOR CONTROLLING REFRACTIVE PROPERTY OF A SMART GLASS THROUGH A DISPLAY DEVICE - A method and system for controlling refractive property of a smart glass includes storing user profiles of a plurality of users in a display device. A user profile includes identifying a user wearing the smart glass. Further, the method includes communicating eye prescription details of the user to the smart glass. The eye prescription details are stored in a user profile. Furthermore, the method includes controlling refractive property of the smart glass based on the eye prescription details. | 07-02-2015 |
Shipra Chaudhary, Sikar IN
Patent application number | Description | Published |
---|---|---|
20140125673 | PRESENTING DATA RECORDS BASED ON BINNING AND RANDOMIZATION - In one embodiment, data records associated with attributes are received. A check is made to determine whether the data records are greater than a maximum data record limit of a graph. Further, when the maximum number of data records in the bin is less than or equal to the maximum data record limit of the graph, the data records are retrieved and presented in the graph. When the data records are greater than the maximum data record limit of the graph, the data records are grouped into bins based on initial bin sizes corresponding to the plurality of attributes. Furthermore, weighted densities of the bins are determined using a maximum number of data records associated with a bin and a maximum data record limit of the bin. Further, the graph is rendered to present the weighted densities of the bins using a randomization technique to analyze the data records. | 05-08-2014 |
Uma Chaudhary, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20100311049 | PCR-Based Kit For Detecting Chlamydia Trachomatis and Nelsseria Gonorrhoeae - The invention relates to a PCR based prototype kit for detecting | 12-09-2010 |
Vishal Chaudhary, Chennai IN
Patent application number | Description | Published |
---|---|---|
20130210365 | METHOD AND SYSTEM FOR ENABLING A MOBILE DEVICE TO INTERFACE WITH A MEDICAL DEVICE - A method and system for enabling a mobile device to interface with a medical device. The embodiments herein relate to patient healthcare monitoring and, more particularly, to use of a mobile device used in patient healthcare monitoring. The embodiments herein disclose a method and system for a mobile device to control or interface with a medical device in a deterministic manner. The mobile application module uses the hardware resources of the mobile device to control or interface with the medical device. This enables the mobile device to fully control or interface with the medical device without any disturbance. | 08-15-2013 |
20140179222 | Method and system for effective and efficient service support - A method and a system for effective and efficient service support provided by the OEM are disclosed. The method provides a Ubiquitous Support Platform (USP) that enables the user or the on-field service personnel to interact with the remote support service centre and/or the R&D teams of the OEM using a mobile device. A secure device or secure software or a programmed NFC tag is integrated in the equipment. The mobile device with audio-video support, communication capability, a mobile software application providing device specific and value added services is disclosed. Thus, the method provides enhanced customer satisfaction and enhanced overall service experience. | 06-26-2014 |
Vishal Chaudhary, Noida IN
Patent application number | Description | Published |
---|---|---|
20150332143 | PROVIDING RELEVANT KNOWLEDGE TO A USER BASED ON THE REQUIREMENTS OF THE USER - Providing relevant knowledge to a user based on the requirements of the user. This invention relates to management of knowledge present with an organization and more particularly to making the knowledge present within an organization available to employees at the right time. The principal object of this invention is to provide a method and system for providing relevant knowledge to a user seamlessly at every specific phase of his/her project development. Another object of the invention is to provide a method and system for providing the relevant knowledge of project phase and technology to a user who is a part of the project, without searching. | 11-19-2015 |